[AsCNP_P16] ポスター16
Neurological Disorders

[AsCNP-P16-5] The deficit of quinolinic acid phosphoribosyltransferase induces hypolocomotion and cognitive impairment through impairment of dopaminergic neuronal function

^○Moe NIIJIMA¹, Akihiro MOURI^{1, 4}, Tomoaki TESHIGAWARA², Kazuo KUNISAWA¹, Hisayoshi KUBOTA¹, Mami HIRAKAWA¹, Yuko MORI², Masato HOSHI², Yasuko YAMAMOTO², Toshitaka NABESHIMA^{3, 4}, Kuniaki SAITO^{2, 4} (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, 2. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Sciences, 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Sciences, 4. Japanese Drug Organization of Appropriate Use and Research)